Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet TARGIN 2.5mg / 1.25mg prolonged-release tablets
- Product code:
- W61019009
- Quantity:
- 98
- Indicated for:
- moderate to severe pain
- Route of administration:
- oral
- Substance:
- oxycodone + naloxone (opioid analgesic + opioid antagonist)
- ATC
- N02AA55 — Nervous system | Opioids | Natural opium alkaloids
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Dependence / abuse
This medicine may cause dependence or be misused.
Respiratory depression
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol
Avoid alcohol during treatment.
Major drug interactions
This medicine may have important interactions with other medicines.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Elderly warning
Older people may have an increased risk of side effects.
Withdrawal / do not stop abruptly
Do not stop treatment abruptly without medical advice.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
The combination of oxycodone and naloxone is used for the treatment of severe pain requiring continuous opioid analgesic administration. Oxycodone is a potent opioid analgesic, while naloxone is an opioid antagonist that reduces the risk of opioid-induced constipation.
The medication is taken orally, usually as extended-release tablets, as directed by your doctor. It is important to follow the prescribed dosage to avoid the risk of dependence or other adverse effects.
Side effects may include nausea, drowsiness, dizziness, constipation, or, in rare cases, respiratory depression.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory or liver diseases, to ensure the safe use of this combination.
The medication is taken orally, usually as extended-release tablets, as directed by your doctor. It is important to follow the prescribed dosage to avoid the risk of dependence or other adverse effects.
Side effects may include nausea, drowsiness, dizziness, constipation, or, in rare cases, respiratory depression.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory or liver diseases, to ensure the safe use of this combination.
General data about TARGIN 2.5mg / 1.25mg
- Substance:
- oxycodone + naloxone
- Date of latest medicines list:
- 01-03-2026
- Product code:
- W61019009
- Concentration:
- 2.5mg / 1.25mg
- Pharmaceutical form:
- prolonged-release tablets
- Quantity:
- 98
- Product type:
- Original
- Prescription status:
- TAB2 — Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.
Pharmaceutical forms available for oxycodone + naloxone
Concentrations available for oxycodone + naloxone
- 10mg/5mg
- 15mg/7.5mg
- 2.5mg/1.25mg
- 20mg/10mg
- 30mg/15mg
- 40mg/20mg
- 5mg/2.5mg
- 60mg/30mg
- 80mg/40mg